Anika Therapeutics, Inc.ANIKNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 130 | 148↑13.3% | 114↓23.0% | 121↑6.1% | 120↓0.7% |
| Gross Profit | 69 | 83↑20.2% | 73↓11.7% | 83↑12.7% | 76↓7.9% |
| Operating Income | -28 | 3↑109.2% | 4↑40.3% | 1↓77.0% | -5↓704.4% |
| Net Income | -24 | 4↑117.2% | -15↓459.4% | -83↓456.3% | -56↑31.8% |
| EBITDA | -1 | -4↓314.6% | 18↑536.2% | 15↓17.1% | 3↓79.9% |
| EPS Diluted | -1.69 | 0.28↑116.6% | -1.02↓464.3% | -5.64↓452.9% | -3.83↑32.1% |